arrow
M

Mangala Rao

walter reed army institute of research
H指数:42
被引数:8,220

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Production of Clinical-Grade SARS-CoV-2 Spike Ferritin Nanoparticle Protein Immunogen by Transient Transfection

通过瞬时转染生产临床级SARS-CoV-2 Spike Ferritin Nanoparticle Protein免疫原

2026-03-030
OAAI
ALFQ adjuvanted HIV-1 envelope protein vaccination elicits durable functional antibody and cellular responses in nonhuman primates

ALFQ佐剂HIV-1包膜蛋白疫苗接种在非人灵长类动物中诱导了持久的抗体和细胞免疫应答。

2025-12-190
OAAI
Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigens

通过展示P. falciparum CSP衍生的抗原的纳米颗粒免疫原,诱导肝脏期免疫

2025-05-050
OA
Loss of HIV candidate vaccine efficacy in male macaques by mucosal nanoparticle immunization rescued by V2-specific response
2024-10-220
OAAI
ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination alone
2023-05-083
OA
Effect of Passive Administration of Monoclonal Antibodies Recognizing Simian Immunodeficiency Virus (SIV) V2 in CH59-Like Coil/Helical or β-Sheet Conformations on Time of SIVmac251 Acquisition
2023-04-274
OA
Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques
2023-04-212
OAAI
Ad26.COV2.S and SARS-CoV-2 spike protein ferritin nanoparticle vaccine protect against SARS-CoV-2 Omicron BA.5 challenge in macaques
2023-04-014
OAAI
SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies
2023-03-1812
OAAI
Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Infection: Founder Envelope V1V2 Impacts the Timing and Magnitude of Autologous Neutralizing Antibodies
2023-02-284
OAAI
Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in E. coli Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants
2022-12-258
OAAI